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BACKGROUND ABSORB EXTEND is a global continued access study
that followed the First-In-Man ABSORB trial. It is aimed at expanding
experience with Absorb bioresorbable everolimus eluting vascular
scaffold (Absorb BVS, Abbott Vascular, Santa Clara, CA, US) to more
geographies and to a larger population of patients, including patients
treated for longer lesions using planned overlapping of scaffolds.
Interim analyses from ABSORB EXTEND have shown the safety and
efﬁcacy of Absorb BVS for the ﬁrst 450 subjects up to 2 years with low
target lesion failure and scaffold thrombosis rates (6.5% and 1.1%,
respectively). The Optical Coherence Tomography (OCT) imaging sub-
study is being conducted within this trial to assess the outcomes
associated with planned overlapping of Absorb BVS.
METHODS A total of 812 patients were enrolled from 56 global sites in this
prospective, single-arm, open-label clinical study. Patients with lesions 
28 mm in length and reference vessel diameter of 2.0 - 3.8 mm were
included with treatment of a maximum of two de novo native coronary
artery lesions, each in a different epicardial vessel. A subset of 14 patients
(designated as the OCT subgroup) who received planned overlapping of
Absorb BVS at designated OCT sites will be assessed using OCT, angiog-
raphy and intravascular ultrasound imaging post-procedure and at 2 years.
RESULTS The mean age of this OCT subgroup was 62.01 years and
85.7% were male. 14.3% of patients had a history of previous MI and
14.3% had a prior cardiac intervention. The mean lesion length was
15.22mm.About 25%of the lesionswere longer than 20mm.Despite the
use of planned overlapping of Absorb BVS, clinical device and proce-
dure success rates were both 100%. OCT and other imaging outcomes
from post-procedure and at 2-year follow-up will be reported.
CONCLUSION The treatment with planned overlapping of Absorb BVS
was highly successful in this small cohort of OCT subgroup patients.
The 2-year imaging results will provide further information on the
feasibility and long term outcomes of longer lesion treatment using
planned overlapping of Absorb BVS.
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BACKGROUND The relative failure of PCI in proximal LAD compared to
CABG remains an important challenge for interventional cardiologists.
Numerous trials comparing CABG to PCI in proximal LAD from the
balloon angioplasty toBMS toDES era, demonstrated that CABGhas less
TVF rates compared to PCI driven by less repeat revascularizations in
theCABGarm. IVUS-guided PCI trials clearly suggest that patients in the
IVUS - guided arm consistently had stents which were larger in diam-
eter. This led us to think that the possible cause of failure in the prox-
imal LAD could be because of under-sizing of the proximal LAD by
Quantitative Coronary Angiography.We set out to test this fact by doing
simultaneous IVUS and QCA measurements of the proximal LAD in a
series of 50 patients undergoing PCI to the LAD. We present illustrative
QCA and IVUS images of a patient to demonstrate our contention.METHODS The proximal LAD was deﬁned as the segment of LAD be-
tween the ostium and the ﬁrst diagonal artery. Simultaneous QCA and
motorized IVUS-pullback studies using ATLANTIS PRO 40Mhz IVUS
probe were done in all patients undergoing PCI to LAD. We measured
the LAD diameter at the ostium, and prior to its bifurcation with the
ﬁrst diagonal by IVUS .Two cross-sectional measurements of the LAD
were done at each point .We took an average of these four values to
arrive at the diameter of the proximal LAD. These values were then
compared to the maximum QCA value obtained along the length of
the proximal LAD.
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measurements of the proximal LAD diameters (media to media) of our
subjects were consistently 3.5 mm or above irrespective of the height,
weight, age, sex, body surface area and presence or absence of dia-
betes or hypertension. We also demonstrated that QCA consistently
underestimates the diameter in the proximal LAD when compared to
IVUS measurements by 0.74 mm on average.CONCLUSION Our ﬁndings have led us to change our practice
signiﬁcantly in the direction of aggressive proximal optimization of
LAD with 3.5 mm diameter balloons or greater as suggested by IVUS
measurements. We conclude that IVUS could add signiﬁcant value in
intervention in proximal LAD and further reduce TVF rates in prox-
imal LAD.
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sions comparing QCA and IVUS-guided angioplasty to ascertain
whether application of IVUS improves outcomes in this subset of
patients.
TCTAP A-079
Vascular Edge Response After Percutaneous Coronary Intervention Using
Serial Optical Coherence Tomography
Yun-Kyeong Cho,1 Hyuck Jun Yoon,1 Chang-Wook Nam,1
Seung-Ho Hur,1 Kwon-Bae Kim1
1Keimyung University Dongsan Medical Center, Korea (Republic of)
BACKGROUND The purpose of this study was to investigate the
vascular response at the proximal and distal edges of the drug-eluting
stent (DES) using optical coherence tomography (OCT).
METHODS A total of 40 patients with 45 lesions were examined by
OCT immediately post-implantation and at follow-up. Quantitative
and qualitative measurement was performed at the adjacent proximal
as well as distal vessel segments to the implanted DES less than 1mm
interval.
RESULTS Mean follow-up duration was 320.6 +- 95.5 days. Distal edge
showed trend of decreased mean lumen area (from 6.56 +- 2.30 mm2
to 6.25 +- 2.16 mm2, p¼0.031). At proximal edge, mean lumen area was
signiﬁcantly decreased at follow-up compared with post-procedure
(from 9.57 +- 3.04 mm2 to 8.77+- 3.38 mm2, p¼0.001). Compared with
proximal edge, distal edge showed trend of lesser degree of lumen
loss (-0.31 +- 0.95 mm2 vs.-0.80 +- 1.54 mm2, p¼0.058). Thin-cap
ﬁbroatheroma (TCFA) was observed in 13.3% of enrolled stents (6/45)
immediately after stenting, and in 8.9 %(4/45) at the follow-up
(3: persistent, 1: new-onset). And edge dissection was observed in 20%
(9/45) immediately after stenting, and 2.2% (1/45) at the follow-up.
CONCLUSION The OCT-based assessment of the edge response in
showed lumen loss at proximal edge. While half of TCFA was
remained, almost of edge dissection was healed. However, larger co-
horts study will be needed to validate these preliminary results.
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BACKGROUND Recently, percutaneous coronary intervention (PCI) of
the unprotected left main trunk (LMT) with a second-generation drug-
eluting stent (DES) is increasingly performed. The objective of this
study is to examine the neointimal response after LMT-PCI with a
second-generation DES by FD-OCT and to evaluate the safety of the
procedure.
METHODS Fifty patients who underwent PCI for LMT with a second-
generation DES and were analyzed by FD-OCT 6-8 months after PCI
were included in this study.
RESULTS Single stenting was performed in 39 patients (Biolimus-
Eluting Stent (BES) ¼16, Everolimus-Eluting Stent (EES) ¼23), and
double stenting (Culotte stenting) in 11. 1)Single-stenting group: The
struts were well covered irrespective of the stent (93.2% with BES,
94.2% with EES).The rate of malapposed struts was extremely low
(2.9% with BES, 1.0% with EES).The neointima on the strut was
thicker with EES than BES (8773mm vs. 7259mm, p<0.0001). 2)
Double-stenting group: Contrary to expectations, the percentage of
uncovered struts was signiﬁcantly lower at overlapping sites than
non-overlapping sites (4.9% vs. 7.7%, p¼0.04), and the frequency of
malapposed struts and the neointimal thickness were similar at both
sites.
CONCLUSION At 6-8 months after PCI with the second-generation
DES, stents were well covered by the neointima, even at the over-
lapping site of culotte stenting. Satisfactory neointimal healing after
LMT-PCI with a second-generation DES was observed in our study.TCTAP A-081
Acetylcholine Provocation Test May Estimate the Intimal Coverage in Drug
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BACKGROUND Prior studies showed the impairment of intimal
function after drug eluting stent (DES) implantation caused reste-
nosis, yet the detailed morphology of this phenomenon is still
uncertain.
METHODS Optical coherence tomography (OCT) were performed in 16
stenting sites and divided into two groups based on positive and
negative spasm provocation using acetylcholine. We analyze the
intimal coverage, the consistency of intima including presence of peri-
strut low-intensity area and hollow formation between the struts.
These evaluations were performed at every slice of stent implanted
site.
RESULTS The interval from index procedure to OCT analysis is not
signiﬁcant between the groups, 342 days in provocation positive
group and 329 days in negative group (P¼0.64). We examined 11 le-
sions (1290 slices, 9828 struts) and 5 lesions (636 slices, 4792 struts) in
provocation positive and provocation negative groups respectively.
The number of stent coverage was signiﬁcantly lower in the provo-
cation positive compared to the negative group (5702 versus 2162
struts, P<0.001). Peri-strut low-intensity areas were more frequently
observed in the provocation positive group than the other group (440
versus 239 struts, P<0.001). The hollow formation also were observed
more frequently in the positive group (181 versus 55 slices, P¼0.001).
CONCLUSION The morphological characteristics of intima in the
positive group were different from those in negative group. In chronic
period after DES implantation, acetylcholine provocation test may
estimate the intimal coverage and the delay of the ﬁbrin absorption
process around the struts.
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BACKGROUND Stent edge restenosis due to incomplete lesion
coverage is one of major risk factors for stent failure after drug-eluting
stent implantation. An association between plaque type at stent edge
and edge restenosis has not been evaluated yet. The aim of the pre-
sent study was to assess whether there is an association between
plaque type assessed by optical coherence tomography (OCT) and
edge restenosis after EES implantation.
METHODS In this study, 278 patients with 331 lesions who underwent
OCT-guided EES implantation and 9-12 months scheduled follow-up
angiography were enrolled. By using OCT, plaque type at stent edge
was classiﬁed into the following 4 types: lipid rich plaque, ﬁbrotic
plaque, ﬁbrocalciﬁc plaque, and normal segment.
RESULTS Distal and proximal edges were visible by post stenting OCT
in 323 and 318 edge segments, respectively. The proportion of plaque
type at stent edge was the following, lipid rich; 21%, ﬁbrotic; 45%,
ﬁbrocalciﬁc; 19% and normal segment; 15%. The incidence of edge
restenosis was 4.7 % (30 of 641 edge segments, 17 in proximal edge, 11
in distal edge, 1 in both edge): 12.8% in lipid rich plaque, 2.8% in in
ﬁbrotic plaque, 4.0% in ﬁbrocalciﬁc plaque, and 0% in normal
segment, respectively (p<0.001).
CONCLUSION The present OCT study demonstrated that lipid rich
plaque at the stent edge has impact on edge restenosis after EES im-
plantation. The selection of residual plaque except for lipid rich pla-
que assessed by OCT as landing zone of the stent may allow us to
avoid unnecessarily longer stents without increasing the incidence of
edge restenosis.
